Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 61

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 61
---
 ​           
 ​           
 ​           |       ​ 
 132,750 
  14,000 
       — 
       — |
|:----------------------|:--|:------------|--------:|:--|:------------|--------:|
| Total                 | ​ | $           | 212,500 | ​ | $           | 146,750 |

| (1) | Audit Fees include fees for the standard audit work that needs to be performed each year in order to issue an opinion on the consolidated financial statements of the Corporation. It also includes fees for services that can only be provided by the Corporation’s auditor such as auditing of non-recurring transactions. |

| (2) | Audit-Related Fees include fees assurance and related services that are reasonably related to the performance of the audit or review and are traditionally performed by the independent accountant. |

| (3) | All Other Fees include fees for products and services other than Audit Fees, Audit Related Fees and Tax Fees. |

The Audit Committee does not have formal pre-approval policies and procedures; however, prior to their engagement by us, the Audit Committee approved all of the services performed by Haskell & White LLP as required by SEC regulation.

| ​             | ​                                             |
| Submitted By: | THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS |
| ​             | Chris A. Rallis, Chair                        |
| ​             | Dr. Marco Brughera                            |
| ​             | Dr. Khalid Islam                              |

Governance and Nominating Committee The Governance and Nominating Committee of the Board develops, recommends and oversees the effectiveness of Fennec’s corporate governance guidelines. In addition, the Governance and Nominating Committee oversees the orientation and education of directors and the process of evaluating the Board and its committees. The Governance and Nominating Committee of the Board is charged with nominating activities, including determining desired Board skills and attributes for directors, conducting appropriate and necessary evaluations of the backgrounds and qualifications of possible director candidates, and recommending director nominees for approval by the Board or the Shareholders. The Governance and Nominating Committee is currently composed three independent directors: Dr. Cook (Chair), Dr. Brughera and Mr. Rallis. The Governance and Nominating Committee held three meetings in the fiscal year ended December 31, 2024. Retention of Outside Advisors Fennec’s Corporate Governance Guidelines provide that the Board, each Board committee, the Chairman and the Lead Independent Director (if any), on behalf of the